Moderna, Inc.
Moderna, Inc. (MRNA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · MRNA · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
7
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Moderna, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
MRNA insider buying and selling by quarter
MRNA insider selling · MRNA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · MRNA ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
MRNA executive sell shares · MRNA board member insider trading · MRNA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 27, 2026 | Mock James M CFO | Option | 773 | — | Form 4 |
| May 28, 2026 | Mock James M CFO | Option | 328 | — | Form 4 |
| May 28, 2026 | Mock James M CFO | Other | 159 | $8K | Form 4 |
| May 27, 2026 | Mock James M CFO | Other | 374 | $18K | Form 4 |
| May 27, 2026 | Klinger Shannon Thyme Chief Legal Officer | Option | 773 | — | Form 4 |
| May 28, 2026 | Klinger Shannon Thyme Chief Legal Officer | Option | 328 | — | Form 4 |
| May 28, 2026 | Klinger Shannon Thyme Chief Legal Officer | Other | 159 | $8K | Form 4 |
| May 27, 2026 | Klinger Shannon Thyme Chief Legal Officer | Other | 374 | $18K | Form 4 |
| May 27, 2026 | Hoge Stephen President | Option | 1,437 | — | Form 4 |
| May 28, 2026 | Hoge Stephen President | Option | 610 | — | Form 4 |
| May 28, 2026 | Hoge Stephen President | Other | 295 | $14K | Form 4 |
| May 27, 2026 | Hoge Stephen President | Other | 695 | $33K | Form 4 |
| May 21, 2026 | AFEYAN NOUBAR Director | Option | 9,263 | $177K | Form 4 |
| May 21, 2026 | AFEYAN NOUBAR Director | Sale | 9,263 | $434K | Form 4 |
| May 15, 2026 | Hoge Stephen President | Option | 16,110 | $309K | Form 4 |
| May 15, 2026 | Hoge Stephen President | Option | 37,226 | $713K | Form 4 |
| May 15, 2026 | Hoge Stephen President | Sale | 53,336 | $2.58M⚡ | Form 4 |
| Apr 30, 2026 | Horning Sandra Director | Option | 16,233 | — | Form 4 |
| Apr 30, 2026 | Rubenstein David M. Director | Option | 8,116 | — | Form 4 |
| Apr 30, 2026 | Hussain Abbas Director | Option | 16,233 | — | Form 4 |
| May 1, 2026 | Hussain Abbas Director | Sale | 5,682 | $265K | Form 4 |
| Apr 30, 2026 | NABEL ELIZABETH G Director | Option | 16,233 | — | Form 4 |
| Apr 30, 2026 | Nader Francois Director | Option | 12,174 | — | Form 4 |
| Apr 30, 2026 | Tallett Elizabeth E Director | Option | 4,058 | — | Form 4 |
| Apr 2, 2026 | Mock James M CFO | Option | 1,453 | — | Form 4 |
Klinger Shannon Thyme
Chief Legal Officer
Date
May 28
Shares
159
Price
$47.61
Value
$8K
Klinger Shannon Thyme
Chief Legal Officer
Date
May 27
Shares
374
Price
$47.03
Value
$18K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About MRNA insider trading
MRNA insider trades
Moderna, Inc. (MRNA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Klinger Shannon Thyme (Chief Legal Officer), Hoge Stephen (President), Mock James M (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. MRNA insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Moderna, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
MRNA insider trading · 5 questionsThe insiders of Moderna, Inc. (MRNA) include executives and directors such as Klinger Shannon Thyme (Chief Legal Officer), Hoge Stephen (President), Mock James M (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026